Nifty

:

23161.60

Sensex

:

73832.55

-53.35 (-0.23%)
-150.63 (-0.20%)

Login

Nifty
Sensex

:
:

23161.60
73832.55

-53.35 (-0.23%)
-150.63 (-0.20%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

72/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

1715.10

11-Jun-2026

Open
High
Low
Previous Close

1650
1715.1
1625.7
1633.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

176186
299687980.8
1736.9
416

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,294.38
21.26
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,264.77
0.58%
3.29

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.47
3.40
5.26

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.42
3.39
1.14

PAT CAGR (%)

10 Years
5 Years
3 Years

38.86
-6.01
19.47

P:E (Median)

8 Years
5 Years
3 Years

11.17
13.33
15.13

P:BV (Average)

8 Years
5 Years
3 Years

0.75
1.02
1.11

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.08
6.35
6.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 259.01 196.74 31.65% 179.95 172.20 4.50% 192.65 169.67 13.54% 131.85 105.86 24.55%
Expenses 199.58 171.49 16.38% 143.23 149.63 -4.28% 162.81 156.75 3.87% 119.20 91.58 30.16%
EBITDA 59.43 25.25 135.37% 36.72 22.57 62.69% 29.84 12.92 130.96% 12.65 14.28 -11.41%
EBIDTM 22.95% 12.83% 20.41% 13.11% 15.49% 7.61% 9.59% 13.49%
Other Income 4.63 4.07 13.76% 2.41 2.08 15.87% 1.68 8.06 -79.16% 8.00 1.56 412.82%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 6.50 4.49 44.77% 6.32 5.20 21.54% 5.92 6.17 -4.05% 5.95 5.76 3.30%
PBT 57.56 24.83 131.82% 32.81 29.36 11.75% 25.60 14.81 72.86% 14.70 10.08 45.83%
Tax 14.11 10.04 40.54% 7.89 5.28 49.43% 6.36 5.55 14.59% 3.01 5.63 -46.54%
PAT 43.45 14.79 193.78% 24.92 24.08 3.49% 19.24 9.26 107.78% 11.69 4.45 162.70%
PATM 16.78% 7.52% 13.85% 13.98% 9.99% 5.46% 8.87% 4.20%
EPS 32.43 11.04 193.75% 18.60 17.97 3.51% 14.36 6.91 107.81% 8.72 3.32 162.65%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 259.40 197.66 31.24% 180.26 176.52 2.12% 192.75 170.10 13.32% 131.90 108.61 21.44%
Expenses 195.97 165.97 18.08% 142.74 158.50 -9.94% 161.79 162.54 -0.46% 121.80 97.35 25.12%
EBITDA 63.43 31.69 100.16% 37.52 18.02 108.21% 30.96 7.56 309.52% 10.10 11.26 -10.30%
EBIDTM 24.45% 16.03% 20.81% 10.21% 16.06% 4.44% 7.66% 10.37%
Other Income 4.95 4.07 21.62% 2.52 2.37 6.33% 1.71 7.93 -78.44% 8.69 1.59 446.54%
Interest 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.02 -50.00% 0.01 0.02 -50.00%
Depreciation 6.76 4.71 43.52% 6.56 5.41 21.26% 6.17 6.40 -3.59% 6.18 5.98 3.34%
PBT 61.61 31.04 98.49% 33.47 24.88 34.53% 26.49 9.07 192.06% 12.60 6.85 83.94%
Tax 14.12 10.04 40.64% 7.89 5.28 49.43% 6.36 5.56 14.39% 3.00 5.63 -46.71%
PAT 47.49 21.00 126.14% 25.58 19.60 30.51% 20.13 3.51 473.50% 9.60 1.22 686.89%
PATM 18.31% 10.62% 14.19% 11.10% 10.44% 2.06% 7.28% 1.12%
EPS 35.52 15.71 126.10% 19.13 14.66 30.49% 15.06 2.63 472.62% 7.18 0.91 689.01%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 763.46 639.46 575.21 537.66 576.71 514.62 320.23 301.84 355.07 375.45 402.69 Net Sales Growth 18.46% 11.17% 6.98% -6.77% 12.07% 60.70% 6.09% -14.99% -5.43% -6.76% Cost Of Goods Sold 387.26 374.79 352.22 336.70 377.50 336.68 176.81 181.78 205.42 186.69 194.64 Gross Profit 376.20 264.68 223.00 200.96 199.22 177.94 143.42 120.06 149.65 188.76 208.05 GP Margin 49.28% 41.39% 38.77% 37.38% 34.54% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% Total Expenditure 624.82 569.47 514.32 476.14 507.89 467.76 277.16 267.55 311.51 328.16 323.14 Power & Fuel Cost - 4.91 4.99 4.17 3.78 3.39 3.41 3.50 3.02 3.08 2.90 % Of Sales - 0.77% 0.87% 0.78% 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% Employee Cost - 67.21 57.57 47.67 43.75 35.89 33.79 30.26 27.82 25.02 25.02 % Of Sales - 10.51% 10.01% 8.87% 7.59% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% Manufacturing Exp. - 31.19 22.40 25.46 25.48 20.63 18.35 18.98 34.28 75.01 58.94 % Of Sales - 4.88% 3.89% 4.74% 4.42% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% General & Admin Exp. - 23.15 21.23 18.63 15.01 13.76 15.22 9.79 11.86 12.20 10.85 % Of Sales - 3.62% 3.69% 3.47% 2.60% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% Selling & Distn. Exp. - 67.58 55.62 43.24 42.37 57.40 29.59 23.24 29.11 26.17 30.78 % Of Sales - 10.57% 9.67% 8.04% 7.35% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% Miscellaneous Exp. - 0.64 0.31 0.26 0.00 0.00 0.00 0.00 0.00 0.00 30.78 % Of Sales - 0.10% 0.05% 0.05% 0% 0% 0% 0% 0% 0% 0% EBITDA 138.64 69.99 60.89 61.52 68.82 46.86 43.07 34.29 43.56 47.29 79.55 EBITDA Margin 18.16% 10.95% 10.59% 11.44% 11.93% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% Other Income 16.72 20.78 11.32 10.17 8.43 17.76 3.58 4.51 1.19 3.10 0.67 Interest 0.00 0.00 0.00 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 Depreciation 24.69 21.62 25.55 31.37 32.58 34.28 31.05 32.95 32.73 39.32 40.47 PBT 130.67 69.16 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 Tax 31.37 26.51 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 Tax Rate 24.01% 33.53% 34.62% 28.17% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% PAT 99.30 52.56 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 PAT before Minority Interest 99.30 52.56 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.01% 8.22% 5.30% 5.39% 8.49% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% PAT Growth 88.86% 72.33% 5.32% -40.89% -9.73% - - - - - EPS 74.10 39.22 22.76 21.61 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 764.31 647.89 601.45 555.51 600.18 548.12 339.33 321.89 372.41 400.04 418.27 Net Sales Growth 17.07% 7.72% 8.27% -7.44% 9.50% 61.53% 5.42% -13.57% -6.91% -4.36% Cost Of Goods Sold 387.26 378.62 354.69 330.99 386.98 340.79 174.31 181.95 205.08 227.07 238.51 Gross Profit 377.05 269.27 246.76 224.51 213.20 207.33 165.02 139.94 167.33 172.97 179.77 GP Margin 49.33% 41.56% 41.03% 40.42% 35.52% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% Total Expenditure 622.30 584.36 541.85 495.49 538.07 494.35 298.52 289.37 332.94 349.32 337.11 Power & Fuel Cost - 6.36 6.35 5.52 4.71 4.58 4.73 4.86 4.29 4.14 4.01 % Of Sales - 0.98% 1.06% 0.99% 0.78% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% Employee Cost - 75.46 66.95 57.05 52.33 46.02 46.02 42.10 39.31 34.27 32.44 % Of Sales - 11.65% 11.13% 10.27% 8.72% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% Manufacturing Exp. - 36.22 28.77 32.40 31.57 22.86 20.84 21.01 36.10 42.48 15.70 % Of Sales - 5.59% 4.78% 5.83% 5.26% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% General & Admin Exp. - 26.24 23.70 20.70 16.67 16.45 17.57 11.85 13.52 13.26 11.97 % Of Sales - 4.05% 3.94% 3.73% 2.78% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% Selling & Distn. Exp. - 60.81 61.09 48.58 45.80 63.64 35.05 27.60 34.65 28.10 34.48 % Of Sales - 9.39% 10.16% 8.75% 7.63% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% Miscellaneous Exp. - 0.64 0.31 0.26 0.00 0.00 0.00 0.00 0.00 0.00 34.48 % Of Sales - 0.10% 0.05% 0.05% 0% 0% 0% 0% 0% 0% 0% EBITDA 142.01 63.53 59.60 60.02 62.11 53.77 40.81 32.52 39.47 50.72 81.16 EBITDA Margin 18.58% 9.81% 9.91% 10.80% 10.35% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% Other Income 17.87 20.96 11.58 10.32 8.31 19.63 5.31 6.09 2.39 4.28 2.01 Interest 0.04 0.07 0.09 0.12 0.48 13.02 13.34 25.41 35.56 36.38 37.98 Depreciation 25.67 22.51 26.44 32.30 33.53 35.28 32.01 33.98 33.83 40.26 41.68 PBT 134.17 61.91 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 Tax 31.37 26.51 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 Tax Rate 23.38% 36.91% 36.18% 29.95% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% PAT 102.80 45.31 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 PAT before Minority Interest 102.80 45.31 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.45% 6.99% 4.74% 4.78% 6.78% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% PAT Growth 126.78% 59.04% 7.23% -34.75% -34.08% - - - - - EPS 76.72 33.81 21.26 19.83 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 589.49 508.59 478.05 449.41 400.18 332.25 340.95 367.99 394.23 444.43 Share Capital 13.37 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 Total Reserves 576.13 495.22 464.68 436.05 374.09 319.91 328.61 355.65 381.89 432.99 Non-Current Liabilities 18.48 59.86 58.17 45.95 58.81 96.03 136.75 157.89 179.52 212.03 Secured Loans 0.00 0.00 0.00 0.00 0.00 23.92 60.88 86.02 112.69 134.55 Unsecured Loans 0.00 38.68 38.68 38.68 47.52 48.34 55.20 50.84 49.13 56.47 Long Term Provisions 2.90 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 Current Liabilities 105.23 72.81 72.67 82.61 87.82 215.98 254.46 222.61 193.71 177.59 Trade Payables 68.60 51.74 48.51 49.63 68.36 33.96 33.41 27.19 30.56 23.90 Other Current Liabilities 30.55 20.02 23.27 32.23 18.78 99.99 107.61 76.87 45.70 36.63 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 81.42 108.92 117.23 115.70 115.09 Short Term Provisions 6.08 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 Total Liabilities 713.20 641.26 608.89 577.97 546.81 644.26 732.16 748.49 767.46 834.05 Net Block 214.14 202.76 199.68 224.67 244.20 271.47 346.89 369.93 389.38 433.52 Gross Block 600.87 581.97 568.50 578.19 581.73 589.77 674.06 669.01 655.78 660.61 Accumulated Depreciation 386.73 379.21 368.82 353.52 337.53 318.30 327.17 299.08 266.40 227.09 Non Current Assets 277.46 280.26 290.70 313.57 333.08 360.33 478.57 499.96 517.54 575.53 Capital Work in Progress 26.39 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 Non Current Investment 0.16 0.16 0.14 0.14 0.14 0.14 0.14 0.14 28.74 28.74 Long Term Loans & Adv. 33.56 51.76 62.55 61.96 62.34 64.08 66.78 65.13 33.17 32.90 Other Non Current Assets 3.21 4.50 2.23 1.57 1.29 0.00 0.00 0.00 0.00 0.00 Current Assets 435.75 361.00 318.19 264.41 213.74 283.94 253.59 248.53 249.93 258.53 Current Investments 84.09 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 100.49 117.81 113.60 125.63 119.69 136.44 140.94 135.98 139.69 137.69 Sundry Debtors 99.26 89.54 84.92 30.41 16.44 29.78 31.39 44.15 41.91 53.88 Cash & Bank 77.99 67.64 53.30 49.97 30.24 1.44 1.28 3.64 3.15 3.04 Other Current Assets 73.93 8.27 1.78 5.25 47.36 116.28 79.98 64.77 65.18 63.91 Short Term Loans & Adv. 64.59 58.65 44.46 53.15 41.66 60.56 74.83 59.93 65.18 63.91 Net Current Assets 330.51 288.18 245.53 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 Total Assets 713.21 641.26 608.89 577.98 546.82 644.27 732.16 748.49 767.47 834.06

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 560.95 487.55 460.34 440.45 400.28 323.37 332.52 361.91 388.67 437.62 Share Capital 13.37 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 Total Reserves 547.58 474.18 446.97 427.08 374.19 311.03 320.18 349.57 376.33 426.18 Non-Current Liabilities 18.48 59.86 58.17 45.95 58.12 95.82 136.68 158.47 179.52 212.05 Secured Loans 0.00 0.00 0.00 0.00 0.09 24.19 61.29 86.60 112.69 134.57 Unsecured Loans 0.00 38.68 38.68 38.68 46.74 47.87 54.73 50.84 49.13 56.47 Long Term Provisions 2.90 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 Current Liabilities 136.29 79.42 82.57 92.74 97.45 224.58 263.62 230.38 196.81 193.14 Trade Payables 91.86 53.18 50.84 50.17 71.36 36.70 36.00 29.33 29.73 25.14 Other Current Liabilities 36.65 22.53 27.23 37.76 21.10 101.70 110.30 78.47 46.16 42.71 Short Term Borrowings 1.69 2.65 3.61 4.06 4.30 85.58 112.80 121.26 119.16 123.32 Short Term Provisions 6.08 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 Total Liabilities 715.72 626.83 601.08 579.14 555.85 643.77 732.82 750.76 765.00 842.81 Net Block 229.42 218.53 215.96 240.94 261.68 289.37 364.45 389.20 406.18 452.48 Gross Block 636.80 617.51 603.75 612.50 616.32 623.96 707.02 702.77 686.50 679.57 Accumulated Depreciation 407.38 398.98 387.78 371.57 354.63 334.59 342.57 313.57 280.32 227.09 Non Current Assets 264.00 267.30 278.25 301.10 321.82 349.77 467.39 490.50 505.60 565.75 Capital Work in Progress 26.39 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 Non Current Investment 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 4.97 23.16 33.95 33.36 35.03 35.77 38.18 36.53 33.17 32.90 Other Non Current Assets 3.21 4.50 2.23 1.57 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 451.72 359.52 322.83 278.04 234.03 294.00 265.43 260.27 259.41 277.07 Current Investments 84.09 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 100.49 121.69 119.94 125.64 119.99 141.12 142.73 138.17 140.60 143.29 Sundry Debtors 112.22 80.50 76.66 38.60 32.04 30.69 38.04 47.27 47.29 61.59 Cash & Bank 80.10 68.09 54.45 50.40 31.42 2.13 2.81 3.98 3.56 7.07 Other Current Assets 74.82 8.27 1.78 5.01 50.58 120.06 81.85 70.84 67.96 65.12 Short Term Loans & Adv. 65.48 61.88 49.87 58.39 44.88 64.34 76.70 66.00 67.96 65.12 Net Current Assets 315.43 280.11 240.26 185.30 136.59 69.43 1.81 29.88 62.59 83.93 Total Assets 715.72 626.82 601.08 579.14 555.85 643.77 732.82 750.77 765.01 842.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 83.10 35.38 28.05 41.00 132.34 77.75 43.65 51.58 61.77 41.91 PBT 69.16 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 Adjustment 14.01 19.36 22.25 24.83 21.59 40.39 59.20 64.73 69.30 53.72 Changes in Working Capital 14.86 -15.15 -34.53 -28.50 69.69 20.37 3.75 10.27 17.27 -14.82 Cash after chg. in Working capital 98.02 50.87 28.05 41.00 108.89 63.31 43.65 51.58 61.77 41.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.92 -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 Cash From Investing Activity -76.20 -6.94 -50.81 -16.75 55.98 -4.64 -11.27 -11.48 -18.06 3.20 Net Fixed Assets -24.21 -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 Net Investments -65.00 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 Others 13.01 0.49 -39.50 -20.17 48.42 -129.06 -6.22 -28.34 -37.01 53.38 Cash from Financing Activity 0.00 0.00 0.00 -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 Net Cash Inflow / Outflow 6.90 28.44 -22.76 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 Opening Cash & Equivalents 48.51 20.07 42.83 27.70 0.00 0.50 3.64 3.15 3.04 3.52 Closing Cash & Equivalent 55.41 48.51 20.07 42.83 26.45 1.26 1.28 3.64 3.15 3.04

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 86.44 37.29 36.63 41.10 131.84 77.60 45.33 31.19 58.93 46.88 PBT 61.87 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 Adjustment 14.96 20.23 23.33 26.33 21.89 41.56 60.72 66.24 70.61 56.41 Changes in Working Capital 24.53 -12.11 -24.63 -21.64 61.39 20.82 5.37 -7.52 9.96 -13.04 Cash after chg. in Working capital 101.36 52.77 36.63 41.10 108.39 63.16 45.33 31.19 58.93 46.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.92 -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 Cash From Investing Activity -76.25 -7.21 -50.83 -16.73 56.49 -4.75 -11.33 -11.48 -18.32 2.92 Net Fixed Assets -24.21 -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 Net Investments -65.00 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 Others 12.96 0.22 -39.52 -20.15 48.93 -129.17 -6.28 -28.34 -37.27 53.10 Cash from Financing Activity -1.02 -1.08 -0.57 -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 Net Cash Inflow / Outflow 9.18 28.99 -14.77 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 Opening Cash & Equivalents 48.96 21.21 43.26 28.88 1.94 2.03 3.98 0.00 7.07 3.62 Closing Cash & Equivalent 57.52 48.96 21.21 43.26 28.88 1.94 2.81 -19.52 3.56 7.07

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 441.01 380.48 357.63 336.21 313.10 269.21 276.25 298.16 319.42 388.42 ROA 7.76% 4.88% 4.88% 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% ROE 9.57% 6.18% 6.25% 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% ROCE 13.91% 8.77% 8.03% 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% Fixed Asset Turnover 1.08 1.00 0.94 0.99 0.88 0.51 0.45 0.54 0.57 0.63 Receivable days 53.88 55.35 39.15 14.83 16.39 34.86 45.68 44.23 46.56 51.33 Inventory Days 62.30 73.42 81.20 77.63 90.83 158.08 167.43 141.69 134.83 126.05 Payable days 58.60 51.95 53.20 57.04 55.46 42.49 37.63 31.43 27.90 25.33 Cash Conversion Cycle 57.59 76.82 67.15 35.41 51.76 150.45 175.48 154.49 153.50 152.04 Total Debt/Equity 0.00 0.08 0.08 0.09 0.12 0.65 0.86 0.82 0.78 0.74 Interest Cover 0.00 0.00 0.00 0.00 4.23 0.52 -0.12 0.34 0.31 1.08

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 419.65 364.74 344.38 329.50 313.18 262.01 269.42 293.23 314.92 382.47 ROA 6.75% 4.64% 4.50% 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% ROE 8.64% 6.01% 5.90% 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% ROCE 13.17% 8.67% 7.72% 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% Fixed Asset Turnover 1.03 0.99 0.91 0.98 0.88 0.51 0.46 0.54 0.59 0.63 Receivable days 54.28 47.69 37.87 21.48 20.89 36.97 48.37 46.34 49.67 54.45 Inventory Days 62.59 73.32 80.68 74.69 86.94 152.66 159.26 136.61 129.51 124.86 Payable days 69.91 53.52 55.69 57.31 57.86 42.82 37.91 30.30 26.74 26.74 Cash Conversion Cycle 46.96 67.48 62.86 38.86 49.96 146.80 169.72 152.65 152.44 152.57 Total Debt/Equity 0.00 0.08 0.09 0.10 0.13 0.68 0.90 0.85 0.80 0.77 Interest Cover 1099.26 477.45 322.44 76.69 4.73 0.40 -0.17 0.23 0.41 1.09

Top Investors:

tikri partners llp

rajni tarun jain

acadian emerging markets micro-cap equity master fund

nisarg ajaykumar vakharia

investor education and protection fund authority ministry of corporate affairs

Annual Reports:

News Update:

Venus Remedies secures renewal of DSIR R&D recognition for VMRC
4th Jun 2026, 17:45 PM

The renewal confirms that VMRC continues to meet these conditions
Read More
Venus Remedies gets marketing authorization from SFDA for Plerixafor
22nd May 2026, 14:22 PM

This is the first Marketing Authorization Venus Remedies has secured for Plerixafor anywhere in the world
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback